国联期货股指分析师项麒睿认为，本轮上涨的核心驱动正从2025年下半年单一的流动性驱动，转向盈利 预期修复与流动性环境改善共同驱动。 "2025年12月我国制造业PMI超预期回升至扩张区间，表明经济回暖早于预期，这增强了盈利修复主线 的可信度。"项麒睿表示，随着宏观政策显效，工业品价格回暖有望推动PPI进入上行通道，为企业利润 改善奠定基础。同时，美元走弱、人民币汇率走强也提供了流动性支撑。这种双重驱动反映在市场风格 上，表现为大类资产普涨，而非去年小盘成长股单边领涨。 "当前指数的行业权重构成与一年前已明显不同，科技含量更高，板块结构性上涨正精准映射经济中的 结构性亮点。"银河期货金融衍生品分析师孙锋从市场主线的角度补充称，上个月中旬以来的行情主要 围绕"十五五"规划建议进行深度挖掘：从商业航天到人脑工程、无人驾驶，再到半导体设备、有色、金 融等板块，这轮上涨需要想象力，相关板块个股市值总体较小，因此涨速迅猛，带来了显著的赚钱效 应，并在年后吸引更多资金加速入市。 上证综指突破关键点位后，继续上行还是震荡调整？ 2026年第二个交易日，A股延续强势。当日盘中，上证综指一举突破2025年11月14日的阶段高点4 ...

Group 1: Company Updates - ChaoYing Electronics has adjusted the investment amount for its AI computing power high-end printed circuit board expansion project from 1.468 billion RMB to 3.315 billion RMB, aiming to meet stronger demand for high-end PCB products and enhance overseas production capabilities [2] - Baihua Pharmaceutical and Siwei Control have both terminated their plans for control change due to a lack of consensus with the transaction parties, with their stocks set to resume trading on January 7, 2026 [3] - Aihui Long has signed a strategic cooperation framework agreement with Brain Machine Star Chain to enhance market expansion and sales of brain-machine interface products through its strong sales channels in emergency, brain disease diagnosis, and pediatrics [10] Group 2: Performance Forecasts - Zhongtai Co. expects a net profit of 420 million to 480 million RMB for 2025, recovering from a loss of 77.96 million RMB in the previous year due to improved operations of its subsidiary [5] - Lier Chemical anticipates a net profit of 460 million to 500 million RMB for 2025, representing a year-on-year growth of 113.62% to 132.19% due to increased demand for its products [5] Group 3: Financing and Restructuring - Zhejiang Xiantong plans to issue A-shares to no more than 35 specific investors, raising up to 1.05 billion RMB for smart manufacturing projects and working capital [7] - Longjing Environmental Protection has received acceptance from the Shanghai Stock Exchange for its securities issuance application, pending further approvals [8] Group 4: Strategic Partnerships - Fushite has signed a strategic cooperation agreement with Jiangxi Copper Group to enhance collaboration in mining equipment maintenance and expand overseas market development [15] - Pro Pharmaceutical has entered into a strategic cooperation framework agreement with Xi'an Xintong Pharmaceutical Research Co., focusing on long-term collaboration in innovative drug research and outsourced production [15] Group 5: Market Activity and Stock Performance - Jia Mei Packaging's stock price increased by 230.48% from December 17, 2025, to January 6, 2026, prompting a temporary suspension for investigation due to significant price volatility [11] - Guosheng Technology's stock experienced a 370.20% increase from October 31, 2025, to January 6, 2026, leading to a suspension for review due to potential irrational market behavior [20]

Market Overview - On January 6, the three major indices collectively rose, with the Shanghai Composite Index reaching a ten-year high, closing up 1.5% [1] - The total trading volume in A-shares reached 2.83 trillion yuan, an increase of 265 billion yuan compared to the previous trading day [1] - Over 4,100 stocks in the market rose, with 143 stocks hitting the daily limit, marking the second consecutive day of over a hundred stocks reaching the limit [1] - The commercial aerospace and brain-computer interface concepts continued to show strong performance [1] Company Announcements - China Satellite announced that its stock price has risen 156.07% since December 3, 2025, significantly outpacing the 23.92% increase in the military industry and 5.31% in the Shanghai Composite Index, indicating a potential overvaluation [3] - China Satellite warned of high trading risks due to market sentiment and irrational speculation, stating that its stock price is detached from its fundamentals [3] - China Satcom also indicated that its stock price has significantly deviated from its fundamentals, with a notable "hot potato" effect in trading, suggesting a high risk of a price drop [4] - Beidou Star Communication noted that its stock price has deviated by over 20% in the last three trading days, highlighting the high market interest in commercial aerospace concepts, while its main business includes satellite navigation products [5] - LeiKe Defense reported a 58.10% increase in stock price over five consecutive trading days, with no significant changes in fundamentals, indicating potential market overheating [6] - Aerospace Electronics announced a 123.23% increase in stock price since November 27, 2025, significantly higher than industry and index increases, warning of trading risks [7] - Aerospace Universe stated that its stock price has risen significantly, with a projected commercial aerospace revenue contribution of less than 15% for 2025 [8] - Aerospace Changfeng clarified that it does not engage in brain-computer interface or commercial aerospace businesses, despite being categorized as such [10] - Sanbo Brain Science indicated that it does not involve in the research or sales of brain-computer interface products, with minimal impact on its overall revenue [13] - Xiangyu Medical is focusing on non-invasive brain-computer interface technology, with no significant sales achieved yet [14] - Mylande announced that its brain-computer interface products are still in the research and development phase, with no major impact on its financial performance [15] - Fenglong Co. reported a 94.92% increase in stock price over seven consecutive trading days, warning of high speculation risks and potential trading halts if prices continue to rise [20][23]

Group 1 - Xinfeng Pharmaceutical is facing criminal charges for unit bribery, which may negatively impact its profits [2] - Aerospace Electronics has seen a stock price increase of 123.23% since November 27, 2025, significantly outpacing the industry and market, indicating potential irrational market behavior [3] - Chipone Technology has completed the acquisition of Zhudian Semiconductor, gaining a 40% stake and control over the company [4] Group 2 - Chaoying Electronics has increased its investment in AI high-end printed circuit board expansion from 1.468 billion to 3.315 billion yuan, with a production capacity target of 166,500 square meters annually [5] - Yihuilong's Brain Machine Star Chain is developing non-invasive brain-machine interface products, but they are still in early stages and not yet registered [6] - Aerospace Changfeng has confirmed it is not engaged in brain-machine interface or commercial aerospace businesses, despite being categorized as such [7] Group 3 - Guosheng Technology's stock will be suspended for trading on January 7, 2026, due to significant price fluctuations, with a cumulative increase of 370.20% since October 31, 2025 [9] - Xiangyu Medical focuses on non-invasive brain-machine interface technology, with no large-scale sales achieved yet, but aims to cover over 1,000 top-tier hospitals by 2026 [10] - Jiamai Packaging's stock has risen by 230.48% from December 17, 2025, leading to a trading suspension for review [11] Group 4 - Zhongtai Co. expects a net profit of 420 million to 480 million yuan for 2025, recovering from a loss of 77.96 million yuan in the previous year [19] - Lier Chemical anticipates a net profit increase of 113.62% to 132.19% for 2025, driven by rising product demand [20] - Pengding Holdings reported a 30.74% increase in consolidated revenue for December 2025, totaling 424.355 million yuan [21] Group 5 - Times New Materials signed a sales contract for wind turbine blades worth approximately 3.32 billion yuan [31] - Jinggong Steel Structure won a bid for a project worth 824 million yuan, representing 4.46% of its latest audited revenue [32] - Robotech's subsidiary ficonTEC signed a significant contract worth approximately 7.7 million euros for automated optical switch packaging [33]

Company Announcements - Jia Mei Packaging's stock price increased by 230% from December 17, 2025, to January 6, 2026, leading to a suspension for investigation starting January 7, 2026 [2] - Guosheng Technology's stock rose by 370.2% during the same period, prompting a suspension for investigation effective January 7, 2026 [3] - Fenglong Co., Ltd. indicated that it may apply for a suspension if its stock price continues to rise abnormally [4] - Xinfang Pharmaceutical is facing public prosecution for alleged unit bribery [7] - Shengke Communication's second-largest shareholder plans to reduce its stake by no more than 3% [8] - Chip Origin Technology completed the acquisition of Zhudian Semiconductor [9] - Robotech's subsidiary signed a significant contract for automatic optical switch packaging with a Swiss client [10] - Aerospace Changfeng clarified that it does not engage in brain-computer interface or commercial aerospace businesses [12] - Chengjian Development holds 18.91 million shares of Century Space, making it the fourth-largest shareholder [13] - Sanbo Brain Science is not involved in the research, production, or sales of brain-computer interface products [14] - Weisi Medical's new products in the brain-computer interface field are still in the early market cultivation stage [16] - Mairande's products in the brain-computer interface area are also in the research and market cultivation phase [17] - Guankang Technology plans to acquire 100% of Liaojing Electronics, with stock resuming trading [19] - Yahui Long signed a strategic cooperation framework agreement with Brain Machine Star Chain to expand its presence in the brain-computer interface field [20] - China Satellite Communications warned that its stock price is at a historical high and may experience a significant drop [21] - Beidou Star Communication stated that commercial aerospace is just one application scenario for its products and services [22] Financial Performance - Lier Chemical expects a net profit increase of 113.62% to 132.19% for 2025 [39] - Zhongtai Co., Ltd. anticipates a net profit of 420 million to 480 million yuan for 2025, recovering from a previous loss [38] Financing and Capital Increase - Desai Xiwai is planning to issue H-shares and list on the Hong Kong Stock Exchange [40] - Xingye Yinx is also preparing to issue H-shares for listing on the Hong Kong Stock Exchange [41] Other Significant Events - Baotailong's controlling shareholder was ordered to rectify its failure to fulfill a shareholding increase commitment [42] - *ST Changyao's stock may face termination of listing due to negative net assets and other financial issues [43]

Group 1 - The core investment theme for the year revolves around "Musk concepts," particularly in the technology sector, including commercial aerospace, humanoid robots, brain-computer interfaces, intelligent driving, AI applications, and new energy [1][2] - The Shanghai Composite Index has achieved a 13-day consecutive rise, reaching a 10-year high, with trading volume increasing significantly to 2.81 trillion yuan, up 260.2 billion yuan from the previous trading day [1] - The market is currently in a bullish phase, with over 4,100 stocks rising and 143 stocks hitting the daily limit, indicating a strong upward momentum [1] Group 2 - The financial sector, particularly securities, is expected to benefit from the ongoing market rally, with significant trading volume observed, suggesting potential for a wave of upward movement [2][5] - The securities sector is highlighted as having the greatest elasticity, with specific stocks like Tonghuashun, Zhinan Compass, and Dongfang Caifu being identified as key players [5] - The overall market sentiment is optimistic, with expectations for continued strong performance in both technology and financial sectors, indicating a favorable environment for investment opportunities [6]

今日焦点 20CM两连板三博脑科：目前不涉及脑机接口产品的研发、生产及销售 三博脑科公告称，公司股票于2026年1月5日、1月6日连续两个交易日内收盘价格涨幅偏离值累计超过 30%，属于股票交易异常波动情形。公司是以神经专科为特色的医疗服务集团，下属院区主要为患者提 供以高精尖神经外科为主的综合医疗服务。公司目前不涉及脑机接口产品的研发、生产及销售，神经调 控技术带来的收入占公司营业收入比重很小，对公司业绩基本没有影响，敬请注意投资风险。 2连板翔宇医疗：截至2025年末脑机接口相关产品尚未实现规模化销售 翔宇医疗发布异动公告，近期资本市场对人脑工程、脑机接口等概念关注度较高，相关板块股价涨幅较 大。公司目前主要聚焦非侵入式脑机接口技术，覆盖作业疗法、运动疗法、认知言语、吞咽等康复全场 景布局，与当前国际上的侵入式脑机接口技术路线存在差异。公司在脑机接口方面的投入，目前在技 术、产品、渠道市场等方面形成一定的布局，但招投标和销售等具有滞后性，截至2025年末，相关产品 尚未实现规模化销售，营收占比较小。 6天4板中国卫通：目前股价已处于历史最高点，已严重脱离基本面存在短期大幅下跌的风险 中国卫通发布股票交易风 ...

【导读】多只牛股公告 兄弟姐妹们啊，今晚多只商业航天、脑机接口概念的牛股齐发公告，不是停牌核查就是提示风险！ 6天4板北斗星通：商业航天仅为公司产品和服务的应用场景之一 中国卫星（600118）公告，公司股票自2025年12月3日以来收盘价格累计上涨幅度为156.07%，同期申 万军工行业涨幅23.92%，上证A指涨幅5.31%，公司股票短期涨幅明显高于同期行业及上证指数涨幅， 但公司基本面未发生重大变化，存在市场情绪过热、非理性炒作风险，公司股票击鼓传花效应明显，交 易风险极大，存在股价短期快速回落风险。 北斗星通（002151）公告称，公司股票交易价格连续3个交易日收盘价格涨幅偏离值累计超过20%，属 于股票交易异常波动情形。公司留意到近期市场对于商业航天概念股的关注度颇高，公司主营业务为卫 星导航芯片、模组、天线、数据服务，下游应用场景包括测量测绘、智能驾驶、智慧农业、割草机器 人、无人机等，商业航天仅为公司产品和服务的应用场景之一，请投资者注意风险。 航天环宇：预计2025年公司商业航天相关收入占比不足15% 航天环宇公告，公司股票于2025年12月31日、2026年1月5日、1月6日连续三个交易日内 ...

| 最高: 54.97 | 今年:4 | | --- | --- | | 最低:49.98 | 昨收:49 | | 量比: 0.70 | 换手:10 | | 委比:100.00% | 振幅:9. | | 每股收益:-0.49 | 股息(TTI | | 每股净资产:9.50 | 股息率(T | | 52周最高: 54.97 | 52周最低 | 【导读】多只牛股公告 中国基金报记者 泰勒 兄弟姐妹们啊，今晚多只商业航天、脑机接口概念的牛股齐发公告，不是停牌核查就是提示风险！ 6天4板北斗星通： 商业航天仅为公司产品和服务的应用场景之一 北斗星通公告称，公司股票交易价格连续3个交易日收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动情形。公司留意 到近期市场对于商业航天概念股的关注度颇高，公司主营业务为卫星导航芯片、模组、天线、数据服务，下游应用场景包括测量 测绘、智能驾驶、智慧农业、割草机器人、无人机等，商业航天仅为公司产品和服务的应用场景之一，请投资者注意风险。 | 成交量: 74.80万手 | | --- | | 成交额:39.95亿 | | 市盈率(TTM)： | | 市净率:5.79 | | 总市值: ...

| | | 1月6日重要公告精选 | | --- | --- | --- | | 类型 | 公司 | 主要内容 | | 热点 | 三博脑科 | 不涉及脑机接口产品的研发、生产及销售 | | | 航天长峰 | 未实际开展脑机接口等相关业务 | | 项目投资 | 同飞股份 | 拟6亿元投资建设南方总部暨工业领域冷却设备及组件项目 | | 合同中标 | 精工钢构 | 中标杭州产创CBD76号地块项目 | | 股权转让 | 观想科技 | 拟购买辽晶电子100%股份 | | 回购 | 理工能科 | 累计回购3.59%股份 回购股份方案已实施完毕 | | 增减持 | 盛科通信 | 国家集成电路产业投资基金拟减持不超3.00%股份 | | 其他 | 浙江仙通 | 拟定增募资不超10.5亿元 投于研发中心升级建设项目等 | | | 利尔化学 | 预计2025年净利润同比增长113.62%-132.19% 写 簡屋に | 【热点】 三博脑科(301293.SZ)：不涉及脑机接口产品的研发、生产及销售 航天长峰(600855.SH)：未实际开展脑机接口等 相关业务 翔宇医疗(688626.SH)：在脑机接口方面的投入，相关产品尚 ...